Experimental bone putty for spinal surgery falls short in early trial

NCT ID NCT01335243

First seen Jun 23, 2026 · Last updated Jun 23, 2026

Summary

This study tested a special bone graft material (MatriBONE mixed with the patient's own bone marrow) for spinal fusion surgery in people with painful degenerative back problems. The goal was to see how well the bones fused together after 12 months. However, the trial was stopped early, so we don't have clear results on whether it worked better than standard treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Unité d'Orthopédie-Traumatologie rachis II, Pellegrin

    Bordeaux, 33076, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

MatriBONE (a collagen scaffold with tri-calcium phosphate) combined with the patient's own bone marrow

What this could lead to

If successful, this approach could offer a safer alternative to traditional bone grafts for spinal fusion surgery.

What could go wrong

The trial was terminated early, so we don't have enough data to know if it works. It was also a small, early-phase study.

Conditions

The condition(s) this trial relates to.

Ankylosis Joint Diseases Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.